Is Nurix Therapeutics, Inc. overvalued?

Nurix Therapeutics, Inc. (NRIX) — key valuation metrics and fundamentals.

No verdict

Price

$23.52

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.43B

Dividend yield

0.0%

Return on equity

-76.1%

Sector

Healthcare

Fair value compares NRIX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks